Ron Lowy, CEO & Executive Chairman, The RAL Group, LLC, serves on the boards and as an advisor to multiple medical device, education and information technology companies. Mr. Lowy is currently the Executive Chairman of PharmaJet, Inc, a Needle-Free injection technology company. He also serves as Chairman of FluoroFinder, a developer and provider of cloud-based medical research tools , Chairman of the Advisory Board of Phase Holographic imaging, a provider of non-invasive cell imaging technology and as a Director of Cetya Therapeutics, a preclinical research company focused on sickle cell anemia and oncology applications.
Mr. Lowy previously served as the President and CEO of the Biosciences division of Thermo Fisher Scientific, Inc. Prior to that, he was President of Global Connectivity Solutions for ADC Telecommunications. He also served as President and Chief Operating Officer at the KRONE Group. He spent the first 15 years of his career in operations, technology and general management positions at GE Healthcare where he was active in GE’s development of Computerized Tomography (CT), Magnetic Resonance (MR) and multiple other imaging technologies.
Mr. Lowy holds a Bachelor of Science degree in Mechanical Engineering from the University of New Hampshire and an MBA from the University of Wisconsin.